No rise in MS patients’ risk of relapse seen with fertility treatments
Disease relapses are no more likely in women with multiple sclerosis (MS) after fertility treatment than they were before…
Articles by Margarida Maia, PhD
Higher blood levels of Ocrevus lower confirmed disability progression risk
Higher blood levels of Ocrevus (ocrelizumab) is associated with a significantly lower risk of confirmed disability progression during treatment…
Phase 2 trial to determine if low-dose ketamine eases MS fatigue
A Phase 2 clinical trial evaluating whether a low dose of ketamine can ease fatigue in people with multiple sclerosis…
Frequency moving to test agents with remyelination potential
Frequency Therapeutics announced that it is shifting its focus to advancing small molecules that aim to restore myelin, the protective…
Dietitian advice assists MS patients to improve calcium intake: Trial
A tailored diet plan from a dietitian may help people with multiple sclerosis (MS) ingest more calcium from foods,…
Crowdfunding Campaign Launched for MS, Other Clinical Programs
FibroBiologics has launched an online crowdfunding campaign to support the development of potential therapies in the company’s pipeline and advance…
Aubagio Significantly Lowers Plasma NfL Levels in TERIKIDS Trial
Aubagio (teriflunomide) can significantly reduce plasma neurofilament light chain (pNfL) levels, a biomarker of nerve cell damage, in children…
MS Relapse, Worse Disease More Likely for Smokers: New Study
People with relapsing-remitting multiple sclerosis (RRMS) who are receiving oral disease-modifying therapies (DMTs) are still…
MS Comorbidities Lead to Economic Burden for Patients, Study Finds
About half of all individuals diagnosed with multiple sclerosis (MS) have at least one other co-occurring medical disorder, and…
No Increase in Disease Activity With Longer Lag in Rituximab Treatment
People with relapsing-remitting multiple sclerosis (RRMS) who are stable on rituximab treatment may receive the therapy at extended…
New Patent Filed for EmtinB With Copaxone as Potential MS Therapy
NeuroScientific Biopharmaceuticals has filed a patent in Australia to protect the use of its lead candidate EmtinB in combination…
Newer Neurologic Therapies Costly, Less Likely to Be Used
Fewer than 1 in 5 people living with multiple sclerosis (MS) or 10 other neurological conditions in the U.S.
Eating Lots of Acidic Foods Linked to Worse, Longer Depression in MS
Eating a lot of acidic foods like meat, eggs, cheese, and grains — and fewer alkaline ones, such as fruits,…
Good Immune Responses to CMV Infection Linked to Better Outcomes
People with good immune responses against the human cytomegalovirus (CMV), a common herpes virus, around the time of their first…
SPMS Patients on Mayzent Show Stable Disease in Real-world Study
Almost two-thirds of a group of 108Â secondary progressive multiple sclerosis (SPMS) patients being treated with Mayzent (siponimod) remained…
How Nasal Foralumab Affects Healthy Immune System: Study
Foralumab nasal spray, an experimental therapy by Tiziana Life Sciences that’s being tested for multiple sclerosis and…
Trial to Assess Adherence to PoNS Therapy for MS With at-Home Use
An upcoming observational clinical trial will assess how adherence to treatment with the portable neuromodulation stimulator (PoNS) device, used…
Expanded Access Program of Nasal Foralumab Enrolls 4 SPMS Patients
A group of four patients have entered a special program where they’ll gain access to foralumab nasal spray, an…
NMSS Grant Supports Work Into Epstein-Barr Virus as MS Trigger
A National Multiple Sclerosis Society grant is supporting an Australian-led research team aiming to better understand how the Epstein-Barr virus…
4 Weeks of Nabiximols Found to Ease Spasticity in MS Pilot Study
Four weeks of treatment with nabiximols — an oral spray containing compounds found in the cannabis plant — significantly reduced…
NIH Grant to Test ‘Shaky’ Treadmill Training to Prevent Falls With MS
A research team at Marquette University has received a $3.34 million grant from the National Institutes of Health (NIH) to test…
Iron Rim Lesions in Brain Linked to a More Severe Disease Course
The presence of iron rim lesions, which are regions of chronic inflammation seen on MRI scans, may be linked to…
High-intensity Resistance Training May Help MS Patients With Fatigue
Three months of once-weekly sessions of high-intensity resistance training — consisting of strength exercises followed by a short recovery between…
Research Collaboration to Study COVID-19 Vaccine Dosing, Timing
The Accelerated Cure Project (ACP) for multiple sclerosis (MS) is teaming up with Quest Diagnostics to study…
Eye Scans May Help to Diagnose MS in Children
A machine learning approach based on eye scans was employed by researchers to diagnose multiple sclerosis (MS) in children…
RRMS Onset Taking Place at Older Ages Over Past 50 Years
The first symptoms of relapsing-remitting multiple sclerosis (RRMS) have been appearing increasingly later in life, according to a Spanish…
Natalizumab, Biosimilar of Tysabri for Relapsing MS, Under FDA Review
The U.S. Food and Drug Administration (FDA) has agreed to review an application requesting that Polpharma Biologics‘ natalizumab, a…
Case Suggests Soliris as Potential Treatment for Progressive MS
Note: This story was updated July 20, 2022, to correct the headline to reflect that Soliris might be a…
Uncontrolled Hypertension More Likely in Black Americans With MS
Black Americans with multiple sclerosis (MS) have a higher chance of having uncontrolled…
High Immune Cell Counts in Blood May Be Linked to MS, Study Finds
Higher numbers of immune cells circulating in the bloodstream may mean a greater likelihood of developing multiple sclerosis (MS),…